Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304529 | PMC |
| http://dx.doi.org/10.1148/rycan.259016 | DOI Listing |
Publication Analysis
Top Keywords
cu-labeled nanobodies
4
nanobodies monitor
4
monitor cd4+
4
cd4+ t-cell
4
t-cell populations
4
populations response
4
response immunotherapy
4
immunotherapy pet
4
pet imaging
4
cu-labeled
1
Similar Publications
Development and comparison of Ga/F/Cu-labeled nanobody tracers probing Claudin18.2.
Mol Ther Oncolytics
December 2022
Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Road, Shanghai 200127, China.
Claudin 18.2 (CLDN18.2) is an emerging target for the treatment of gastric cancers.
View Article and Find Full Text PDF